You have 9 free searches left this month | for more free features.

Adefovir

Showing 26 - 50 of 196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HBV Trial in Kaohsiung (Tenofovir Alafenamide Tablets)

Recruiting
  • HBV
  • Tenofovir Alafenamide Tablets
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Dec 21, 2020

Parathyroid Hormone, Tenofovir Disoproxil Fumarate, Chronic Hepatitis, B Virus Without Hepatitis Delta (Diagnosis) Trial in

Not yet recruiting
  • Parathyroid Hormone
  • +3 more
  • Ergocalciferol Capsules
  • Calcium carbonate
  • Bangkok Noi, Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital, Mahidol University
Mar 28, 2022

Renal Function of Patients With Chronic Hepatitis B in China

Unknown status
  • Hepatitis B, Chronic
    • Guangzhou, Guangdong, China
      The Third Affiliated Hospital of Sun Yat-Sen University
    Sep 3, 2020

    Hepatitis B Trial in China (Tenofovir disoproxil fumarate (TDF) tablets, Adefovir dipivoxil (ADV) tablets)

    Completed
    • Hepatitis B
    • Tenofovir disoproxil fumarate (TDF) tablets
    • Adefovir dipivoxil (ADV) tablets
    • Guangzhou, Guangdong, China
    • +19 more
    Jun 13, 2018

    Chronic Viral Hepatitis B Without Delta-agent Trial in Seoul (Tenofovir, Entecavir)

    Completed
    • Chronic Viral Hepatitis B Without Delta-agent
    • Seoul, Korea, Republic of
      Asan Medical Center
    Feb 18, 2018

    Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)

    Unknown status
    • Chronic Hepatitis B
    • stopping nucleos(t)ide therapy
    • Continue nucleos(t)ide analogue
    • Singapore, Singapore
      National University Hospital
    Sep 24, 2019

    Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB China

    Completed
    • Chronic Hepatitis B
      • Beijing, Beijing, China
      • +54 more
      Jul 13, 2020

      Hepatitis B, Chronic Trial in Shatin, New Territories (Lamivudine, Adefovir dipivoxil, Fixed dose combination (Lamivudine and

      Completed
      • Hepatitis B, Chronic
      • Shatin, New Territories, Hong Kong
        GSK Investigational Site
      Aug 2, 2017

      Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48 Trial (lamivudine plus

      Unknown status
      • Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
      • lamivudine plus adefovir combination
      • Tenofovir Disoproxil Fumarate
      • (no location specified)
      Jul 28, 2017

      Hepatitis B Trial run by the NIDDK (Tenofovir & Emtricitabine, Tenofovir)

      Terminated
      • Hepatitis B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      May 23, 2019

      Hepatitis B, Chronic, Chronic Kidney Diseases Trial in Hong Kong (Telbivudine)

      Completed
      • Hepatitis B, Chronic
      • Chronic Kidney Diseases
      • Hong Kong, Hong Kong
        Department of Medicine, The University of Hong Kong, Queen Mary
      Dec 15, 2018

      HEPSERA Post Marketing Surveillance

      Completed
      • Hepatitis B
      • adefovir dipivoxil
      • (no location specified)
      Jun 6, 2017

      Nomogram Analysis for HBV Related Acute-on-chronic Liver Failure

      Completed
      • Liver Failure
      • No special intervention was suitable for this observational study
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-sen University
      Jan 2, 2020

      HCC Patients After Curative Treatment With Low HBV Viral Load Trial in Kaohsiung, Taipei (Vemlidy® (Tenofovir Alafenamide; TAF),

      Recruiting
      • HCC Patients After Curative Treatment With Low HBV Viral Load
      • Vemlidy® (Tenofovir Alafenamide; TAF)
      • Placebo
      • Kaohsiung, State..., Taiwan
      • +3 more
      Jul 5, 2021

      Hepatitis B, Chronic Trial in China (Tenofovir Alafenamide 25 MG)

      Recruiting
      • Hepatitis B, Chronic
      • Tenofovir Alafenamide 25 MG
      • Bengbu, Anhui, China
      • +9 more
      Nov 15, 2020

      Hepatitis B, Chronic Trial in Guangzhou (Telbivudine, Adefovir dipivoxil)

      Completed
      • Hepatitis B, Chronic
      • Telbivudine, Adefovir dipivoxil
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-sen University
      Oct 22, 2017

      Entecavir for Decompensated HBV Cirrhosis

      Completed
      • Hepatitis B
      • Liver Cirrhosis
      • Lucknow, UP, India
        Sanjay Gandhi Postgraduate Institute of Medical Sciences
      Sep 23, 2019

      Cirrhosis of Liver Due to Hepatitis B (Disorder) Trial in Guangzhou (pegylated interferon (Peg IFN)a-2b, Nucleoside

      Recruiting
      • Cirrhosis of Liver Due to Hepatitis B (Disorder)
      • pegylated interferon (Peg IFN)α-2b
      • Nucleoside (acid)analogue (NAs)
      • Guangzhou, Guangdong, China
        Third Affliated Hospital of Sun Yat-sen University
      Jun 19, 2019

      Chronic Hepatitis B Trial in China (ePA-44, Placebo)

      Completed
      • Chronic Hepatitis B
      • εPA-44
      • Placebo
      • BeiJing, Beijing, China
      • +14 more
      Sep 17, 2019

      Chronic Hepatitis b, Hepatic Carcinoma Trial in Shanghai (ETV;TDF;ADV, Peginterferon Alfa-2a)

      Unknown status
      • Chronic Hepatitis b
      • Hepatic Carcinoma
      • Shanghai, China
        Huashan Hospital
      Sep 6, 2017

      Hepatitis B, Chronic Trial in Taiwan (Adefovir, Entecavir, Placebo)

      Completed
      • Hepatitis B, Chronic
      • Adefovir
      • +3 more
      • Changhua, Taiwan
      • +8 more
      Mar 10, 2017

      Post-operative HBV-related Hepatocellular Carcinoma

      Terminated
      • Hepatocellular Carcinoma
      • Adefovir Dipivoxil and Lamivudine
      • Kaohsiung, Taiwan
      • +7 more
      Apr 26, 2017

      Hepatitis B, Chronic Trial in Barcelona (Telbivudine, oral adefovir)

      Completed
      • Hepatitis B, Chronic
      • Barcelona, Spain
        Novartis Investigative Site
      Mar 24, 2017

      Difficult-to-treat CHB Patients:Comparison Between TDF

      Completed
      • The Difficult-to-treat Chronic Hepatitis B
        • Seoul, Korea, Republic of
          Department of Internal Medicine, Yonsei University College of Me
        Jul 15, 2018